Standout Papers

Genome-wide association study of alcohol consumption and use disorder ... 2016 2026 2019 2022 277
  1. Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations (2019)
    Henry R. Kranzler, Hang Zhou et al. Nature Communications
  2. Gabapentin misuse, abuse and diversion: a systematic review (2016)
    Rachel Vickers‐Smith, Jennifer R. Havens et al. Addiction
  3. Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis (2024)
    Amira Guirguis, Stefania Chiappini et al. European Neuropsychopharmacology

Immediate Impact

6 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Obesity in adults
2024 Standout
The benefits of GLP-1 drugs beyond obesity
2024 StandoutScience
1 intermediate paper

Works of Rachel Vickers‐Smith being referenced

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
2023

Author Peers

Author Last Decade Papers Cites
Rachel Vickers‐Smith 275 216 100 180 56 1.3k
Xiaohui Xu 141 53 13 92 63 1.6k
Luigi Cipolloni 166 96 38 62 65 1.5k
Dimitrios Kouvelas 120 161 98 56 90 1.4k
Tae Suk Kim 327 76 28 65 55 1.5k
Geoffrey P. Redmond 47 282 29 183 37 1.6k
Maarten Pieter Rozing 115 71 85 112 69 1.5k
F Grodstein 205 313 44 99 30 1.2k
Aimilia Mantzou 101 107 8 136 92 1.3k
Vı́ctor Navarro 257 57 25 136 62 1.5k
S. V. Madhu 192 107 65 88 75 1.3k

All Works

Loading papers...

Rankless by CCL
2026